Results 161 to 170 of about 14,868 (228)

心筋虚血・梗塞と心臓自律神経機能 [PDF]

, 1993
井上 博
core   +1 more source

Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025. [PDF]

Endocr J
Tanabe A, Katabami T, Hashimoto S, Izawa S, Ichijo T, Otsuki M, Oriuchi N, Kinuya S, Kinoshita H, Kimura N, Shibata H, Sone M, Takahashi K, Takizawa N, Takekoshi K, Tsuiki M, Tanase-Nakao K, Nakamura Y, Nishimoto K, Hasegawa T, Murakami M, Yonamine M, Naruse M.   +22 more
europepmc   +1 more source

Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided management. [PDF]

Insights Imaging
Choucair A, Zdunek A, Liao M, Bodei L, Deandreis D, Das J, Barbe R, Bergsland E, Geyer S, Bidault F, Garcia G, Yeh R, Balleyguier C, Lassau N, Dercle L, Ammari S.   +15 more
europepmc   +1 more source

Ga-68 DOTATATE PET imaging in the management of head and neck paragangliomas: a potential game changer. [PDF]

Front Oncol
Alduraibi A, Bin Essa N, Alruwaili AA, Bomanji J.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

I-131-MIBG therapies

Methods, 2011
Metaiodobenzylguanidine (MIBG) is a tracer that selectively targets neuroendocrine cells. On this basis, radiolabeled iodinated-MIBG (I-131-MIBG) has been introduced as a molecular nuclear therapy in the management of neuroendocrine tumors, including neuroblastoma, pheochromocytoma, paraganglioma, neuroendocrine carcinomas, and other rare ...
Felix M Mottaghy
exaly   +3 more sources

MIBG Activity in the Gallbladder

Clinical Nuclear Medicine, 2016
Whole-body I-MIBG images were acquired in a 12-year-old girl who had metastatic malignant paraganglioma to assess the extent of the metastases. Image quality was suboptimal because of diffusely increased muscle activity, which was related to the labetalol the patient took to control her blood pressure.
Xia, Bai, Hongming, Zhuang
openaire   +2 more sources

Enhancement of 131I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBG

Nuclear Medicine Communications, 2000
Iodine-131 metaiodobenzylguanidine (131I-MIBG) has been used with success for the palliation of symptomatic, metastatic carcinoid tumours. However, only 70% of cases are MIBG-avid and tumour uptake is not always sufficient for therapy. At The Netherlands Cancer Institute 34 carcinoid patients with no or insufficient uptake were treated with escalating ...
C A, Hoefnagel, B G, Taal, F, Sivro, H, Boot, R A, Valdes Olmos   +4 more
openaire   +2 more sources

1-23I-MIBG thyroid uptake: Implications for MIBG imaging of the heart

Journal of Nuclear Cardiology, 2016
123I-MIBG has been widely used in patients with heart failure and neurological disorders. The patients are pre-treated with Lugol's oral solution or potassium perchlorate to prevent thyroid uptake of unlabeled 123I to limit the thyroid radiation exposure. However, despite the inhibition of the iodide pump, the thyroid is frequently visualized.
GIUBBINI, Raffaele, Milan, Elisa, Marcassa, Claudio, Paghera, Barbara, Fracassi, Federica, Camoni, Luca, RODELLA, Carlo, BERTAGNA, Francesco, MOTTA, Federica, Bertoli, Mattia, Campini, Riccardo   +10 more
openaire   +3 more sources